Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus -1: an in vitro study on virally infected Vero and MRC-5 cell lines

New sources for discovering novel antiviral agents are desperately needed. The current antiviral products are both expensive and not very effective. The antiviral activity of methanol extract of mung bean sprouts (MBS), compared to Ribavarin and Acyclovir, on respiratory syncytial virus (RSV) and He...

Full description

Saved in:
Bibliographic Details
Published in:BMC complementary and alternative medicine 2015-06, Vol.15 (1), p.179-179, Article 179
Main Authors: Hafidh, Rand R, Abdulamir, Ahmed S, Abu Bakar, Fatimah, Sekawi, Zamberi, Jahansheri, Fatemeh, Jalilian, Farid Azizi
Format: Article
Language:English
Subjects:
Acyclovir - pharmacology
Animals
Antiviral Agents - pharmacology
Antiviral Agents - therapeutic use
Beans
Care and treatment
Cercopithecus aethiops
Comparative analysis
Cytokines - metabolism
Fabaceae
Health aspects
Herpes Simplex - drug therapy
Herpes Simplex - metabolism
Herpes Simplex - virology
Herpes simplex virus
Herpesvirus 1, Human - drug effects
Humans
In Vitro Techniques
Legumes
Medical research
Medicine, Experimental
Methanol
Mimosaceae
Phytotherapy
Plant Extracts - pharmacology
Plant Extracts - therapeutic use
Respiratory Syncytial Virus Infections - drug therapy
Respiratory Syncytial Virus Infections - metabolism
Respiratory Syncytial Virus Infections - virology
Respiratory Syncytial Viruses - drug effects
Simplexvirus - drug effects
Vero Cells
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:New sources for discovering novel antiviral agents are desperately needed. The current antiviral products are both expensive and not very effective. The antiviral activity of methanol extract of mung bean sprouts (MBS), compared to Ribavarin and Acyclovir, on respiratory syncytial virus (RSV) and Herpes Simplex virus -1 (HSV-1) was investigated using cytotoxicity, virus yield reduction, virucidal activity, and prophylactic activity assays on Vero and MRC-5 cell lines. Moreover, the level of antiviral cytokines, IFNβ, TNFα, IL-1, and IL-6 was assessed in MBS-treated, virally infected, virally infected MBS-treated, and control groups of MRC-5 cells using ELISA. MBS extract showed reduction factors (RF) 2.2 × 10 and 0.5 × 10(2) for RSV and HSV-1, respectively. The 2 h incubation virucidal and prophylactic selectivity indices (SI) of MBS on RSV were 14.18 and 12.82 versus Ribavarin SI of 23.39 and 21.95, respectively, and on HSV-1, SI were 18.23 and 10.9 versus Acyclovir, 22.56 and 15.04, respectively. All SI values were >10 indicating that MBS has a good direct antiviral and prophylactic activities on both RSV and HSV-1. Moreover, interestingly, MBS extract induced vigorously IFNβ, TNFα, IL-1, and IL-6 cytokines in MRC-5 infected-treated group far more than other groups (P < 0.05) and induced TNFα and IL-6 in treated group more than infected group (P < 0.05). MBS extract has potent antiviral and to a lesser extent, prophylactic activities against both RSV and HSV-1, and in case of HSV-1, these activities were comparable to Acyclovir. Part of the underlying mechanism(s) of these activities is attributed to MBS potential to remarkably induce antiviral cytokines in human cells. Hence, we infer that MBS methanol extract could be used as such or as purified active component in protecting and treating RSV and HSV-1 infections. More studies are needed to pinpoint the exact active components responsible for the MBS antiviral activities.
ISSN:1472-6882
1472-6882
DOI:10.1186/s12906-015-0688-2